UNIVERSITY OF CALIFORNIA – SAN FRANCISCO Research indicates that starting school later in the morning yields health and academic benefits for high schoolers, whose natural body clock tends toward late-to-bed, late-to-rise habits. While parents raise concerns about drowsy driving, irritation and impaired school performance, a new study led by researchers at UC San Francisco suggests...
Tag: <span>Migraine</span>
Post
Psilocybin & migraine: First of its kind trial reports promising results
By Rich Haridy; November 22, 2020 An exploratory trial found a single dose of psilocybin cut migraine frequency by half in the two weeks following taking the drug A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for...
Post
New migraine drugs help halving the instances of migraine attacks
Migraine is a severe headache, which is debilitating and can pretty much prevent people from working or functioning properly. A lot of migraine sufferers have it as a chronic condition, which means that it returns regularly and has to be medicated. However, as this new study from the Monash University has shown, a very effective...
Post
Migraine Nerve Stimulation Device Now Available Over-the-Counter
Megan Brooks The first dual-purpose, external trigeminal nerve stimulation device to treat and prevent acute migraine is now available over-the-counter to adults over age 18. The US Food and Drug Administration (FDA) has cleared Cefaly Dual (Cefaly Technology) which was previously only available by prescription. Most migraines involve the trigeminal nerve, which can be accessed through the...
Post
Green light therapy shown to reduce migraine frequency, intensity
by University of Arizona A study by University of Arizona Health Sciences researchers found that green light therapy resulted in about a 60% reduction in the pain intensity of the headache phase and number of days per month people experienced migraine headaches. Credit: University of Arizona Health Sciences/Kris Hanning New research from the University of Arizona...
Post
FDA approves new drug for migraine sufferers
By Michael Nedelman, CNN A recipe for headache prevention 00:59 (CNN)The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can’t take or don’t respond to migraine medications currently on the market. The drug...
Post
Fragmented sleep may trigger migraine 2 days later
A new study finds that people whose sleep is fragmented during the night are at higher risk of experiencing a migraine episode not the next day, but the day after that. Fragmented sleep might trigger migraine 2 days later, research finds. Dr. Suzanne Bertisch — a physician and clinical investigator in the Division of Sleep...
Post
Does the Location of a Headache Matter?
By Osman Shabir, M.Sc.Reviewed by Dr. Jennifer Logan, MD, MPH Headaches can occur due to a variety of reasons, with most of them not being serious. Whilst there are well over 200 types of headache, there are typically two major types of headaches: primary (90%), in which the headache is a ‘headache-condition’ in itself (for example, migraine...
Post
How does a piece of bread cause a migraine?
by Lauren Green, The Conversation Tens of millions of people worldwide suffer from migraines, according to the World Health Organization. Credit: Maridav/Shutterstock.com Migraine is the third most prevalent illness in the world and causes suffering for tens of millions of people. In fact, nearly 1 in 4 U.S. household includes someone with migraines. Migraine is not just a headache but also...
Post
New antibody treatment provides little relief for high-frequency migraine patients
OREGON HEALTH & SCIENCE UNIVERSITY An early assessment reveals that a newly approved drug to treat migraines does not seem effective among patients who suffer from high-frequency migraines. The findings will be presented this week during the 61st annual scientific meeting of the American Headache Society in Philadelphia. Clinicians at OHSU in Portland, Oregon, conducted...